SCHEMBL327505

SCHEMBL327505

Fc1cccc(Cn2nccc2F)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2B P29275 1/20 0.41
PKM P14618 2/20 0.39
PKLR P30613 1/20 0.39
GUCY1B2 O75343 1/20 0.37
GUCY1A2 P33402 1/20 0.37
GUCY1A1 Q02108 1/20 0.37
GUCY1B1 Q02153 1/20 0.37
GRM2 Q14416 1/20 0.36
RORC P51449 5/20 0.36
P2RX7 Q99572 3/20 0.36
GAA P10253 1/20 0.35
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP2A13 Q16696 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15733013 0.86 ALDH1A1 (0.46) ADORA2AADORA1PKMPKLRGRM2
SCHEMBL3595893 0.85 GRM2 (0.41) ADORA2AADORA1ADORA3ADORA2BPKM
SCHEMBL27925571 0.75 HSP90B1 (0.33) RORC
SCHEMBL15996110 0.72 KDM1A (0.35) ADORA2BPKMALDH1A1MAPTL3MBTL1
SCHEMBL3605369 0.72 GRM2 (0.49) ADORA2AADORA1ADORA3ADORA2BPKM
SCHEMBL28806287 0.72 BRD4 (0.43) ADORA2BPKMRORCGAAALDH1A1
SCHEMBL9287846 0.72 KDM4E (0.47) ADORA2AADORA1ADORA3ADORA2BPKM
SCHEMBL27907467 0.72 GUCY1B2 (0.38) ADORA2AADORA1ADORA3ADORA2BPKM
SCHEMBL3605124 0.71 ALDH1A1 (0.43) ADORA2AADORA1RORCP2RX7GAA
SCHEMBL16371124 0.70 MEN1 (0.30) MAPTMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103097387-B Ring-fused pyrimidines and triazines and use thereof for treating and/or preventing cardiovascular diseases 拜耳知识产权有限责任公司 2016-11-02 CN disclosed
EP-2590979-A1 RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES Bayer Intellectual Property GmbH (DE) 2013-05-15 EP disclosed
CN-103097387-A Ring-fused pyrimidines and triazines and use thereof for treating and/or preventing cardiovascular diseases BAYER IP GMBH 2013-05-08 CN disclosed
WO-2012004258-A9 RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-07 WO disclosed
WO-2012004258-A1 RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-01-12 WO disclosed